News

WASHINGTON — mRNA, a Nobel-winning technology harnessed by Trump officials to create Covid shots in record time, is becoming ...
Pharmaceutical rivals don’t often come to each other’s defense. But after the US Department of Health and Human Services ...
Several mRNA vaccine trials found a debilitating side effect, and now the Trump administration is cutting funding for more ...
Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were ...
This week, mRNA vaccines are set to face intense scrutiny from critics in Congress. Here's an explainer of how we know they ...
In May, prominent members of the Make America Great Again movement, including Nicole Shanahan, Kennedy's former presidential running mate, and media personality Laura Loomer, spoke out against Kennedy ...
Trump HHS ends nearly $1 billion in funding to Moderna for mRNA bird flu vaccines, citing safety concerns and lack of ...
NEXSPIKE becomes Moderna’s third FDA-approved product CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc.
The Trump administration has canceled $766 million awarded to Moderna to develop a vaccine against potential pandemic ...
With COVID cases rising in India and several other countries, many people are wondering whether they should get vaccinated.
Moderna (MRNA) stock in focus as the U.S. FDA approved its next-gen COVID-19 vaccine, mNEXSPIKE,. Read more here.
The U.S. Food and Drug Administration has approved Moderna's next-generation COVID-19 vaccine for everyone aged 65 and above, ...